Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference

NASHVILLE, Tenn., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in H.C. Wainwright’s 5^th Annual Ophthalmology Conference on Wednesday, August 13, 2025, being held virtually.

Read more at globenewswire.com